Examining the relationship between beverage intake and cardiovascular health. Ian Macdonald University of Nottingham UK

Size: px
Start display at page:

Download "Examining the relationship between beverage intake and cardiovascular health. Ian Macdonald University of Nottingham UK"

Transcription

1 Examining the relationship between beverage intake and cardiovascular health Ian Macdonald University of Nottingham UK

2 Outline Assessment of evidence in relation to health risks of dietary components Cardiovascular health/disease Tea Cocoa Milk Red wine

3 Assessment of evidence in diet/nutrition studies Types of studies: cross-sectional epidemiology, cohort studies, randomised controlled trials Systematic review with or without meta-analysis Outcome variables: events or risk factors/markers Limitations of studies Cross-sectional epidemiology: associations, no links to causality or time-trends Cohort studies: confounding from other lifestyle factors. For CVD/metabolic outcomes need to control for smoking, alcohol, BMI, gender, physical activity If looking at dietary macronutrients, what changes/differences exist (eg if CHO goes down what goes up)? RCTs often do not achieve a long term magnitude of change which is intended (eg WHI increase fruit & vegetable intake)

4 Cardiovascular health Tea Peters et al (2001) - tea associated with reduced CVD risk (although 3 studies showed increased risk) Arab et al (2009) - meta-analysis of green and black tea and stroke >3 cups a day reduced stroke risk by 21% (no difference between black or green tea) Wang et al (2011) - meta-analysis of links between tea and coronary artery disease (CAD). 13 on black tea (USA and Europe) 5 on green tea (China and Japan). No significant association was found between black tea consumption and CAD. Green tea associated with reduced risk of CAD (10% decrease for 1 cup/day). (Ethnic / regional confounding?)

5 Arab et al Stroke reduction

6 Wang et al, Black tea and CAD

7 Wang et al, Green tea and CAD Geleijnse et al (1999) - Rotterdam Heart study, clinically diagnosed atherosclerosis and tea intake - Significant negative association. Relative risk was 1 for <125ml/d, 0.54 for ml/d, 0.31 for >500ml/d

8 Tea: CV health markers BP no apparent effect of tea on BP. Acute consumption may even increase it (caffeine?) Cholesterol some indication that green tea may reduce total and LDL cholesterol FMD Ras et al (2011) meta-analysis of intervention studies investigating tea and endothelial function. FMD 2.6% greater with 500ml/d of tea compared to placebo.

9 Taubert et al Tea and BP RCTs

10 Ras 2011 Tea and FMD RCTs

11 Tea and CV Health: Longer term RCTs Hartley et al (2013) Systematic Review of RCTs of >3 months, duration. 11 studies -7 looked at the effects of green tea, and 4 at black tea. Green tea reduced total cholesterol, and BP. Black tea reduced LDL cholesterol and BP. Black Tea LDL Black Tea SBP BUT only 2 studies for both black & green tea

12 Cardiovascular Health Cocoa Analysis of 7 countries/zutphen studies suggested cocoa/chocolate may be associated with reduced CV disease risk Several recent reports of potentially beneficial effects (RCTs) of acute and chronic cocoa flavanol intake, from high flavanol cocoa drinks, on BP and endothelial function

13 Taubert et al Cocoa and BP RCTs

14 Flavonoids and type 2 DM Balzer et al, JACC 2008 (Balzer et al, 2008) 963mg 963mg Entry Baseline Dose 963mg 30 days 371mg 75mg 75mg Reduction in LDL, no change in BP at 30 days

15 Cognitive function, BP and cocoa flavanols in elderly subjects (CoCoA study) Desideri et al group of 30 elderly subjects (71yr) with MCI received low (45mg), medium (520mg) or high (990mg) doses of CF daily for 8 weeks Cognitive function (MMSE, Trails A and B, verbal fluency), BP measured and blood samples taken for insulin, glucose, lipids. Saw cognitive improvements (partly dose related), reduction in BP and Insulin Resistance estimates. Latter was associated statistically with the cognitive changes

16

17 Milk and BP Livingstone KM, Lovegrove JA, Cockcroft JR, Elwood PC, Pickering JE Hypertension in the highest group of milk consumption systolic blood pressure was 10.4 mm Hg lower (P trend=0.033) than in non-milk consumers after a 22.8-year follow-up

18 Cardiovascular Health Red wine Vidavalur et al (2006) - systematic review of wine and CVD risk. Wine drinkers had higher HDL and ApoA1 and lower lipoprotein(a) than non-drinkers. Moderate red wine consumption was associated with reduced platelet aggregation, (possibly due to reduced prostanoid synthesis) reduced fibrinogen, and increased fibrinolytic activity. Some of the CVD benefits may be due to red wine increasing NO dependant signalling.

19 Cardiovascular Health Red wine Chiva-Blanch et al (2013) - evidence relating red wine consumption and CVD. Stated that: Clear that heavy alcohol consumption is associated with increased mortality and morbidity. Moderate alcohol intake, especially drinks high in polyphenols, confer CVD protective effects, both in healthy volunteers and those with high CVD risk. However, most of these effects/associations are weak and not consistent across groups of subjects Overall the evidence for CV Health benefits is not convincing

20 Conclusions Some reasonable evidence of potential benefits for CV Health in relation to tea intake Whether there are major differences between green and black tea remain to be determined, and the confounding from ethnic/lifestyle differences in relation to tea consumption need to be resolved Whether any effect of tea is due to the flavanoids remains to be confirmed, but if this is the case then other beverage sources of flavanoids (Cocoa, Orange Juice) may also be of interest and the current level of research into effects of cocoa flavanols may generate some important findings

Flavonoids and Cardiovascular Disease

Flavonoids and Cardiovascular Disease Flavonoids and Cardiovascular Disease Julie Lovegrove Hugh Sinclair Professor of Human Nutrition University of Reading Micronutrients and Health APPG University of Reading 2014 www.reading.ac.uk Global

More information

JoAnn E. Manson, MD, DrPH Howard D. Sesso, ScD, MPH Brigham and Women's Hospital Harvard Medical School

JoAnn E. Manson, MD, DrPH Howard D. Sesso, ScD, MPH Brigham and Women's Hospital Harvard Medical School The COcoa Supplement and Multivitamin Outcomes Study (COSMOS): A Randomized Trial of Cocoa Flavanols and Multivitamins in the Prevention of CVD and Cancer JoAnn E. Manson, MD, DrPH Howard D. Sesso, ScD,

More information

Flavonoids and their contribution to health: a look at the scientific support

Flavonoids and their contribution to health: a look at the scientific support Flavonoids and their contribution to health: a look at the scientific support Frank Hu, MD, PhD Professor of Nutrition and Epidemiology Harvard School of Public Health Professor of Medicine Harvard Medical

More information

Antioxidants in food, drinks and supplements for cardiovascular health

Antioxidants in food, drinks and supplements for cardiovascular health Position statement Antioxidants in food, drinks and supplements for cardiovascular health This position statement provides recommendations for the consumption of antioxidantrich food, drinks and supplements

More information

THE SAME EFFECT WAS NOT FOUND WITH SPIRITS 3-5 DRINKS OF SPIRITS PER DAY WAS ASSOCIATED WITH INCREASED MORTALITY

THE SAME EFFECT WAS NOT FOUND WITH SPIRITS 3-5 DRINKS OF SPIRITS PER DAY WAS ASSOCIATED WITH INCREASED MORTALITY ALCOHOL NEGATIVE CORRELATION BETWEEN 1-2 DRINKS PER DAY AND THE INCIDENCE OF CARDIOVASCULAR DISEASE SOME HAVE SHOWN THAT EVEN 3-4 DRINKS PER DAY CAN BE BENEFICIAL - WHILE OTHERS HAVE FOUND IT TO BE HARMFUL

More information

Heart Disease Genesis

Heart Disease Genesis Heart Disease Genesis The Ultimate Lecture on CAD origins Petr Polasek MD FRCPC FACC Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

The COSMOS Trial. (COcoa Supplement and Multivitamins Outcomes Study) JoAnn E. Manson, MD, DrPH Howard D. Sesso, ScD, MPH

The COSMOS Trial. (COcoa Supplement and Multivitamins Outcomes Study) JoAnn E. Manson, MD, DrPH Howard D. Sesso, ScD, MPH COSMOS Trial The COSMOS Trial (COcoa Supplement and Multivitamins Outcomes Study) JoAnn E. Manson, MD, DrPH Howard D. Sesso, ScD, MPH Brigham and Women's Hospital Harvard Medical School Garnet L. Anderson,

More information

A Proposed Randomized Trial of Cocoa Flavanols and Multivitamins in the Prevention of Cardiovascular Disease and Cancer

A Proposed Randomized Trial of Cocoa Flavanols and Multivitamins in the Prevention of Cardiovascular Disease and Cancer A Proposed Randomized Trial of Cocoa Flavanols and Multivitamins in the Prevention of Cardiovascular Disease and Cancer JoAnn E. Manson, MD, DrPH Howard D. Sesso, ScD, MPH Brigham and Women's Hospital

More information

Metabolic Factors Frequency of Chocolate Consumption and Body Mass Index

Metabolic Factors Frequency of Chocolate Consumption and Body Mass Index School of Medicine, Health Sciences and Engineering Susquehanna Township High School Lecture Series Week 23, February 4 2014 Clinical Relevance of This Week s Topic Metabolic Factors Frequency of Chocolate

More information

Dairy consumption and cardiometabolic health do the trials support the epidemiology?

Dairy consumption and cardiometabolic health do the trials support the epidemiology? Dairy consumption and cardiometabolic health do the trials support the epidemiology? Karen Murphy, PhD RNutr & Georgina Crichton Food Industry Forum, 31 st August 2010 Dairy Australians are eating 1-1.5

More information

Traditional Asian Soyfoods. Proven and Proposed Cardiovascular Benefits of Soyfoods. Reduction (%) in CHD Mortality in Eastern Finland ( )

Traditional Asian Soyfoods. Proven and Proposed Cardiovascular Benefits of Soyfoods. Reduction (%) in CHD Mortality in Eastern Finland ( ) Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com 1000 80 20 60 40 40 60 20 80

More information

Sugar-Loaded Beverages and the Impact on Cardiovascular Health. Christina M. Shay, PhD, MA

Sugar-Loaded Beverages and the Impact on Cardiovascular Health. Christina M. Shay, PhD, MA Sugar-Loaded Beverages and the Impact on Cardiovascular Health Christina M. Shay, PhD, MA 1 Presenter Disclosure Information Christina M. Shay, PhD, MA Sugar-Loaded Beverages and the Impact on Cardiovascular

More information

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Total risk management of Cardiovascular diseases Nobuhiro Yamada Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible

More information

ICPH 2013 Buenos Aires, Argentina October 19 th, 2013

ICPH 2013 Buenos Aires, Argentina October 19 th, 2013 Flavonoids and Cardiovascular Health What Progress Has Been Made Towards Public Health Recommendations for Flavonoids? Carl L. Keen Department of Nutrition University of California, Davis clkeen@ucdavis.edu

More information

The impact of dairy products on cardiovascular health

The impact of dairy products on cardiovascular health The impact of dairy products on cardiovascular health D Vasilopoulou 2014 1 Overview CVD mortality in UK Does dairy consumption increase the risk of CVD? Dairy intake as part of healthy lifestyle RESET

More information

Nutrients and Circulatory Function

Nutrients and Circulatory Function Clinical Nutrition Research Centre Nutrients and Circulatory Function Peter Howe Clinical Nutrition Research Centre University of Newcastle Nutritional Physiology Research Centre University of South Australia

More information

Cardiovascular Outcome

Cardiovascular Outcome Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children: Cardiovascular Outcome D R. J E F F R E Y G O L D B E R G E R U

More information

Cocoa beans as the starting ingredients in manufacturing dark chocolate

Cocoa beans as the starting ingredients in manufacturing dark chocolate Cocoa beans as the starting ingredients in manufacturing dark chocolate Raw cocoa beans contain large amounts of flavanols Polyphenols Flavonoids Flavonols Flavones Isoflavones Flavanones Anthocyanidins

More information

Consumption of different types of alcohol and mortality

Consumption of different types of alcohol and mortality Consumption of different types of alcohol and mortality 1 di 6 Results Consumption of different types of alcohol and mortality We know that a moderate amount of alcohol consumption is beneficial for health.

More information

Overview of effects of alcohol intake on cardiovascular disease

Overview of effects of alcohol intake on cardiovascular disease Beverage specific effects Overview of effects of alcohol intake on cardiovascular disease Dr. Ramon Estruch Department of Internal Medicine, Barcelona University, Spain. CIBER OBN Institute of Health Carlos

More information

SFRBM Annual Meeting, Pre-meeting Workshop II Flavanols in Health and Disease

SFRBM Annual Meeting, Pre-meeting Workshop II Flavanols in Health and Disease FLAVIOLA Targeted delivery of dietary flavanols for optimal human cell function: Effects on cardiovascular health SFRBM Annual Meeting, Pre-meeting Workshop II Flavanols in Health and Disease Flavanol

More information

Cocoa in cardiovascular medicine. Remedy or hype?

Cocoa in cardiovascular medicine. Remedy or hype? Cocoa in cardiovascular medicine. Remedy or hype? Andreas Flammer, MD, FESC University Heart Center Zurich Switzerland andreas.flammer@usz.ch Conflict of interest: none Chocolate: Popular for thousands

More information

Proven and Proposed Cardiovascular Benefits of Soyfoods

Proven and Proposed Cardiovascular Benefits of Soyfoods Proven and Proposed Cardiovascular Benefits of Soyfoods Mark Messina, PhD, MS Soy Nutrition Institute Loma Linda University Nutrition Matters, Inc. markjohnmessina@gmail.com Alpro Foundation 20 years symposium

More information

EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION

EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION 1 A STUDY ON THE EFFECT OF DIET & LIFE STYLE ON THE INCIDENCE OF CORONARY ARTERY DISEASE IN MODERATELY DRINKING EX MILITARY MEN IN PATHANAMTHITTA DISTRICT. EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT

More information

Tea Expert Newsletter Issue five. Scientific update on tea, flavonoids and blood pressure

Tea Expert Newsletter Issue five. Scientific update on tea, flavonoids and blood pressure Tea Expert Newsletter Issue five Scientific update on tea, flavonoids and blood pressure Scientific update on tea, flavonoids and blood pressure From the editors The worldwide epidemic of cardiovascular

More information

Ketogenic Diets-good, bad, indifferent? Peter Clifton CSIRO Human Nutrition

Ketogenic Diets-good, bad, indifferent? Peter Clifton CSIRO Human Nutrition Ketogenic Diets-good, bad, indifferent? Peter Clifton CSIRO Human Nutrition Presenter Disclosure Information

More information

Dyslipidemia in women: Who should be treated and how?

Dyslipidemia in women: Who should be treated and how? Dyslipidemia in women: Who should be treated and how? Lale Tokgozoglu, MD, FACC, FESC Professor of Cardiology Hacettepe University Faculty of Medicine Ankara, Turkey. Cause of Death in Women: European

More information

Clinical Recommendations: Patients with Periodontitis

Clinical Recommendations: Patients with Periodontitis The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;

More information

Update in Hypertension

Update in Hypertension Update in Hypertension Eliseo J. PérezP rez-stable MD Professor of Medicine DGIM, Department of Medicine UCSF 20 May 2008 Declaration of full disclosure: No conflict of interest (I have never been funded

More information

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

Chocolate, red wine, peanuts health foods or indulgences? Alison Coates, PhD, RNutr

Chocolate, red wine, peanuts health foods or indulgences? Alison Coates, PhD, RNutr Chocolate, red wine, peanuts health foods or indulgences? Alison Coates, PhD, RNutr Annual Food Industry Forum for Nutrition Research August 31 st 201 0 Functional Foods Chocolate, red wine and peanuts

More information

Gemma Cooper University of Nottingham

Gemma Cooper University of Nottingham Gemma Cooper University of Nottingham mbxgc@nottingham.ac.uk Outline Introduction to flavanols What are flavanols? What do flavanols do? Flavanols In the diet In apples and apple juice My work Current

More information

Cardiovascular Risk Assessment and Management Making a Difference

Cardiovascular Risk Assessment and Management Making a Difference Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy

More information

ASSeSSing the risk of fatal cardiovascular disease

ASSeSSing the risk of fatal cardiovascular disease ASSeSSing the risk of fatal cardiovascular disease «Systematic Cerebrovascular and coronary Risk Evaluation» think total vascular risk Assess the risk Set the targets Act to get to goal revised; aupril

More information

Blood Pressure Acre Surgery Diviash Thakrar

Blood Pressure Acre Surgery Diviash Thakrar Blood Pressure Acre Surgery Diviash Thakrar Why Are We Doing This? 1. Improve education for patients within the practice 2. Allow us use this for general health promotion Raise money for charity 3. Raise

More information

Dyslipidemia in the light of Current Guidelines - Do we change our Practice?

Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dyslipidemia in the light of Current Guidelines - Do we change our Practice? Dato Dr. David Chew Soon Ping Senior Consultant Cardiologist Institut Jantung Negara Atherosclerotic Cardiovascular Disease

More information

Risk Factors for NCDs

Risk Factors for NCDs Risk Factors for NCDs Objectives: Define selected risk factors such as; tobacco use, diet, nutrition, physical activity, obesity, and overweight Present the epidemiology and significance of the risk factors

More information

Cardiovascular health benefits of plant-based eating

Cardiovascular health benefits of plant-based eating Cardiovascular health benefits of plant-based eating Ian Rowland University of Reading Alpro Foundation Student Symposium March 2017 Leeds Overview What is plant-based eating? Cardiovascular disease Benefits

More information

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam

John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:

More information

Lipid Management 2013 Statin Benefit Groups

Lipid Management 2013 Statin Benefit Groups Clinical Integration Steering Committee Clinical Integration Chronic Disease Management Work Group Lipid Management 2013 Statin Benefit Groups Approved by Board Chair Signature Name (Please Print) Date

More information

Put your Heart before your Head

Put your Heart before your Head Put your Heart before your Head Alok K Gupta, MD, FAAFP, FASH Associate Professor, Outpatient Clinic since 1963, the US Congress has required the President to proclaim February "American Heart Month."

More information

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple

More information

Fructose in diabetes: Friend or Foe. Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism

Fructose in diabetes: Friend or Foe. Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism Fructose in diabetes: Friend or Foe Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism Contents What is Fructose? Why is Fructose of Concern? Effects of Fructose on glycemic

More information

Low carbohydrate diets- do they have a place?

Low carbohydrate diets- do they have a place? Low carbohydrate diets- do they have a place? Grant Schofield Professor of Public Health AUT University, Auckland NZ @grantsnz www.facebook.com/profgrant www.profgrant.com Atherogenic dyslipidemia is [primarily]

More information

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION Management of Hypertension: Treatment Thresholds and Medication Selection Robert B. Baron, MD MS Professor and Associate Dean Declaration of full disclosure: No conflict of interest Presentation Goals

More information

OUR MISSION: DELIVERING THE PROOF OF THE

OUR MISSION: DELIVERING THE PROOF OF THE OUR MISSION: DELIVERING THE PROOF OF THE HEALTH EFFECTS REVIEW OF THE LATEST RESEARCH INTO DIETARY RISKS TO CARDIO HEALTH AND THEIR IMPLICATIONS FOR FOOD DEVELOPMENT ERIC CHAPPUIS DIRECTOR, CONSULTING

More information

Exploring the links between Food, Diet and Non-Communicable Disease

Exploring the links between Food, Diet and Non-Communicable Disease Exploring the links between Food, Diet and Non-Communicable Disease Evidence and Controversies Ian T Johnson Emeritus Fellow, Quadram Institute Bioscience, Norwich Almost everything we think we know about

More information

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG Diabetes Mellitus: Update 7 What is the unifying basis of this vascular disease? Eugene J. Barrett, MD, PhD Professor of Internal Medicine and Pediatrics Director, Diabetes Center and GCRC Health System

More information

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension. 2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature

More information

The Mediterranean Diet: The Optimal Diet for Cardiovascular Health

The Mediterranean Diet: The Optimal Diet for Cardiovascular Health The Mediterranean Diet: The Optimal Diet for Cardiovascular Health Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health Cardiovascular Disease Prevention International

More information

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials PREVENTING CARDIOVASCULAR DISEASE IN WOMEN: Current Guidelines for Hypertension, Lipids and Aspirin Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial

More information

Clinical Care Performance. Financial Year 2012 to 2018

Clinical Care Performance. Financial Year 2012 to 2018 Clinical Care Performance Financial Year 2012 to 2018 SHP Clinical Care Performance Diabetes Mellitus Hyperlipidemia Hypertension Diabetes Mellitus Find out how our patients are doing for: HbA1C HbA1c

More information

Overview. The Mediterranean Diet: The Optimal Diet for Cardiovascular Health. No conflicts of interest or disclosures

Overview. The Mediterranean Diet: The Optimal Diet for Cardiovascular Health. No conflicts of interest or disclosures The Mediterranean Diet: The Optimal Diet for Cardiovascular Health No conflicts of interest or disclosures Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health

More information

T. Suithichaiyakul Cardiomed Chula

T. Suithichaiyakul Cardiomed Chula T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial

More information

The Clinical Unmet need in the patient with Diabetes and ACS

The Clinical Unmet need in the patient with Diabetes and ACS The Clinical Unmet need in the patient with Diabetes and ACS Professor Kausik Ray (UK) BSc(hons), MBChB, MD, MPhil, FRCP (lon), FRCP (ed), FACC, FESC, FAHA Diabetes is a global public health challenge

More information

WHICH DIET FOR THE PREVENTION OF CARDIOVASCULAR DISEASE MEAT OR VEGETARISM

WHICH DIET FOR THE PREVENTION OF CARDIOVASCULAR DISEASE MEAT OR VEGETARISM WHICH DIET FOR THE PREVENTION OF CARDIOVASCULAR DISEASE MEAT OR VEGETARISM QUELLE ALIMENTATION POUR PRÉVENIR LES MALADIES CARDIOVASCULAIRES VIANDE OU VÉGÉTARISME Dr Jean-Michel LECERF Service de Nutrition

More information

Cardiovascular Disease Prevention: Current Knowledge, Future Directions

Cardiovascular Disease Prevention: Current Knowledge, Future Directions Cardiovascular Disease Prevention: Current Knowledge, Future Directions Daniel Levy, MD Director, Framingham Heart Study Professor of Medicine, Boston University School of Medicine Editor-in-Chief, Journal

More information

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines Conflict of Interest Disclosure Updates for the Ambulatory Care Pharmacist: Dyslipidemia and CV Risk Assessment No conflicts of interest to disclose 2014 Updates to the Updates in Ambulatory Care Pharmacy

More information

Cho et al., 2009 Journal of Cardiology (2009), 54:

Cho et al., 2009 Journal of Cardiology (2009), 54: Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal

More information

Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C

Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C Thomas P. Bersot, M.D., Ph.D. Gladstone Institute of Cardiovascular Disease University

More information

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016 Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October

More information

Patient is healthy with no chronic disease or significant risk factors [16%].

Patient is healthy with no chronic disease or significant risk factors [16%]. AAFP Risk Level 1 Patient is healthy with no chronic disease or significant risk factors [16%]. Exclude the following chronic problems from active patient list o Depression o Diabetes Type I or Type II

More information

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015

Complications of Diabetes mellitus. Dr Bill Young 16 March 2015 Complications of Diabetes mellitus Dr Bill Young 16 March 2015 Complications of diabetes Multi-organ involvement 2 The extent of diabetes complications At diagnosis as many as 50% of patients may have

More information

Should we base treatment decisions on short-term or lifetime CVD risk? Rod Jackson University of Auckland New Zealand

Should we base treatment decisions on short-term or lifetime CVD risk? Rod Jackson University of Auckland New Zealand Should we base treatment decisions on short-term or lifetime CVD risk? Rod Jackson University of Auckland New Zealand Presentation outline Strengths & weaknesses of short-term risk approach Strengths &

More information

Dairy matrix effects on T2 diabetes and cardiometabolic health?

Dairy matrix effects on T2 diabetes and cardiometabolic health? Department of Nutrition, Exercise and Sports Dairy matrix effects on T2 diabetes and cardiometabolic health? Arne Astrup Head of department, professor, MD, DMSc. Department of Nutrition, Exercise and Sports

More information

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING THE DECREASE

More information

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids: CARDIOVASCULAR DISEASES (CVD) and NUTRITION Major cause of morbidity & mortality in Canada & other developed countries e.g., majority of approved health claims on food labels relate to lowering CVD Relation

More information

Cardiovascular System and Health. Chapter 15

Cardiovascular System and Health. Chapter 15 Cardiovascular System and Health Chapter 15 Cardiovascular Disease Leading cause of death in U.S. Claims 1 life every 43 seconds Often, the first sign is a fatal heart attack Death Rates #1 CVD #2 Cancer

More information

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized

More information

L III: DIETARY APPROACH

L III: DIETARY APPROACH L III: DIETARY APPROACH FOR CARDIOVASCULAR DISEASE PREVENTION General Guidelines For Dietary Interventions 1. Obtain a healthy body weight 2. Obtain a desirable blood cholesterol and lipoprotein profile

More information

Report Operation Heart to Heart

Report Operation Heart to Heart Report Operation Heart to Heart Elkhorn Logan Valley Public Health Department (Burt, Cuming, Madison, and Stanton Counties) Gina Uhing, Health Director Ionia Research Newcastle, Nebraska Joseph Nitzke

More information

No relevant financial relationships

No relevant financial relationships MANAGEMENT OF LIPID DISORDERS Balancing Benefits and harms Disclosure Robert B. Baron, MD MS Professor and Associate Dean UCSF School of Medicine No relevant financial relationships baron@medicine.ucsf.edu

More information

Using Scientific Nutrition Research to Reach Millennial Consumers

Using Scientific Nutrition Research to Reach Millennial Consumers FLORIDA DEPARTMENT OF CITRUS Using Scientific Nutrition Research to Reach Millennial Consumers Rosa Walsh, Ph.D. Florida Department of Citrus September 20, 2018 Connecting with Millennial Moms 3 4 A Healthy

More information

Saturated fat- how long can you go/how low should you go?

Saturated fat- how long can you go/how low should you go? Saturated fat- how long can you go/how low should you go? Peter Clifton Baker IDI Heart and Diabetes Institute Page 1: Baker IDI Page 2: Baker IDI Page 3: Baker IDI FIGURE 1. Predicted changes ({Delta})

More information

HDL-C. J Jpn Coll Angiol, 2008, 48: NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart

HDL-C. J Jpn Coll Angiol, 2008, 48: NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart Online publication March 25, 2009 48 6 2007 2007 HDL-C LDL-C HDL-C J Jpn Coll Angiol, 2008, 48: 463 470 NIPPON DATA80, MEGA study, JELIS, dyslipidemia, risk assessment chart 1987 NIPPON DATA80 Iso 10 MRFIT

More information

The Diabetes Link to Heart Disease

The Diabetes Link to Heart Disease The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM

More information

Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary

More information

Long-Term Complications of Diabetes Mellitus Macrovascular Complication

Long-Term Complications of Diabetes Mellitus Macrovascular Complication Long-Term Complications of Diabetes Mellitus Macrovascular Complication Sung Hee Choi MD, PhD Professor, Seoul National University College of Medicine, SNUBH, Bundang Hospital Diabetes = CVD equivalent

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Cardiovascular risk potential of dietary saturated fats: an update and some implications

Cardiovascular risk potential of dietary saturated fats: an update and some implications Cardiovascular risk potential of dietary saturated fats: an update and some implications Gerard Hornstra, PhD Med" Prof. Em. of Experimental Nutrition" Maastricht University" The Netherlands" Cardiovascular

More information

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society

More information

Managing HTN in the Elderly: How Low to Go

Managing HTN in the Elderly: How Low to Go Managing HTN in the Elderly: How Low to Go Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of the Women s Cardiovascular

More information

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center

Treatment of Cardiovascular Risk Factors. Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Treatment of Cardiovascular Risk Factors Kevin M Hayes D.O. F.A.C.C. First Coast Heart and Vascular Center Disclosures: None Objectives What do risk factors tell us What to check and when Does treatment

More information

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

Your Name & Phone Number Here! Longevity Index

Your Name & Phone Number Here! Longevity Index Your Name & Phone Number Here! Longevity Index Your Health Risk Analysis is based on a variety of medical and scientific data from organizations such as the American Heart Association, American Dietetic

More information

Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s

Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s Understanding new international guidelines to tackle CV Risk: A practical model John Deanfield, MD UCL, London United Kingdom s Ho Chi Minh City, Vietnam August 7, 2014 JBS 2 Risk Guidelines (2005) Based

More information

Estrogens vs Testosterone for cardiovascular health and longevity

Estrogens vs Testosterone for cardiovascular health and longevity Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in

More information

Results/ conclusion. Reference Duration Number subjects. Study description. Limitations of the data. Randomized controlled trial (RCT)

Results/ conclusion. Reference Duration Number subjects. Study description. Limitations of the data. Randomized controlled trial (RCT) (original) Appel, 1997 8 weeks 459 459 ; all received a control SAD for 3 weeks then randomized to (i) control (ii) a diet rich in fruits and veg (FV) or (iii) a combination diet (combo) rich in fruits,

More information

Placebo-Controlled Statin Trials Prevention Of CVD in Women"

Placebo-Controlled Statin Trials Prevention Of CVD in Women MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Association between arterial stiffness and cardiovascular risk factors in a pediatric population + Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro

More information

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona,

Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Marshall Tulloch-Reid, MD, MPhil, DSc, FACE Epidemiology Research Unit Tropical Medicine Research Institute The University of the West Indies, Mona, Jamaica At the end of this presentation the participant

More information

Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies

Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies Mohsen Mazidi 1, Niki Katsiki 2, Dimitri P. Mikhailidis 3, Maciej Banach

More information

Heart Health. Team Member Workbook Session 1 LEARN IDENTIFY ACT. Learn about HTHU Level 3 and the point system

Heart Health. Team Member Workbook Session 1 LEARN IDENTIFY ACT. Learn about HTHU Level 3 and the point system LEARN Learn about HTHU Level 3 and the point system 01 IDENTIFY Identify the major risk factors for cardiovascular disease and how to improve our cardiovascular health 03 02 ACT Begin our Session 1 Goal

More information

Fructose, Uric Acid and Hypertension in Children and Adolescents

Fructose, Uric Acid and Hypertension in Children and Adolescents Fructose, Uric Acid and Hypertension in Children and Adolescents Daniel I. Feig, MD, PhD, MS Director, Division of Nephrology Department of Pediatrics University of Alabama, Birmingham Topics for Discussion

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

Title:Dark chocolate and reduced snack consumption in mildly hypertensive adults: an intervention study

Title:Dark chocolate and reduced snack consumption in mildly hypertensive adults: an intervention study Reviewer's report Title:Dark chocolate and reduced snack consumption in mildly hypertensive adults: an intervention study Version:1Date:8 June 2015 Reviewer:Katherine Keene Reviewer's report: Minor Issues

More information

Disclosures. Overview 9/30/ ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Disclosures. Overview 9/30/ ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults 2013 ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults 2014 AAHP Fall Seminar Sherry Myatt, PharmD, BCPS Assistant Director of Pharmacy for

More information

Identification of subjects at high risk for cardiovascular disease

Identification of subjects at high risk for cardiovascular disease Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet

More information